RA Capital Nexus Fund, L.P., Director, 10% Owner at Tyra Biosciences, Inc. (TYRA), bought 1,692,721 shares at $16.00 ($20.0M) on 2021-09-17, disclosed to the SEC on 2021-09-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 442,721 | $0 | 0.0% |
| 2 | $16.00 | 1,250,000 | $20.0M | 100.0% |
| Total | $11.82 avg | 1,692,721 | $20.0M | 100% |
| Filing → |
| ETNB | BUY | 2022-10-20 | $17.9M | — | Filing → |
| ETNB | BUY | 2022-07-06 | $10.0M | — | Filing → |